Eris Lifesciences Limited (BOM: 540596)

Market Cap	187.87B
Revenue (ttm)	24.85B
Net Income (ttm)	3.48B
Shares Out	n/a
EPS (ttm)	25.58
PE Ratio	53.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,259
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	810.10 - 1,593.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jan 21, 2025

About Eris Lifesciences

Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India. The company offers various branded formulations in various therapeutic areas, such as anti–diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women’s health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measureme...

• Industry: Pharmaceutical Preparations
• Founded: 2007
• Employees: 3,620
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540596

Financial Performance

In 2023, Eris Lifesciences's revenue was 19.91 billion, an increase of 19.83% compared to the previous year's 16.62 billion. Earnings were 3.92 billion, an increase of 2.57%.